Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00294_DB00307_nanopub.RADnx-h_i-A_3mpG1wYPZ0t7j1OFVKJhi4ecnRJxmeioI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00294_DB00307 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00294_DB00307 label "DDI between Etonogestrel and Bexarotene - Bexarotene may decrease the serum concentration of Contraceptives (Progestins). Since bexarotene is teratogenic and can lower serum concentrations of etonogestrel, it is advised that women of childbearing potential use two forms of contraception (including at least one non-hormonal form). [drugbank_resource:DB00294_DB00307]" assertion.
- drugbank_resource:DB00294_DB00307 identifier "drugbank_resource:DB00294_DB00307" assertion.
- drugbank_resource:DB00294_DB00307 title "DDI between Etonogestrel and Bexarotene - Bexarotene may decrease the serum concentration of Contraceptives (Progestins). Since bexarotene is teratogenic and can lower serum concentrations of etonogestrel, it is advised that women of childbearing potential use two forms of contraception (including at least one non-hormonal form)." assertion.
- drugbank:DB00307 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00294_DB00307 assertion.
- drugbank:DB00294 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00294_DB00307 assertion.